Syra Health Continues its Focus on Improving Mental Health with Another Contract Win in the State of Missouri

CARMEL, Ind., June 27, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that it has secured a contract with the Missouri Department of Mental Health to provide qualified behavioral health professionals for various locations throughout the state.

According to the National Alliance on Mental Illness (NAMI), 871,902 people in Missouri live in a community that does not have enough mental health professionals.

This is Syra Health's second active contract in the state of Missouri. Syra Health announced in March that it had secured a healthcare workforce contract for providing temporary medical services personnel throughout the state. The previous contract includes recruiting specialized medical professionals specific to Missouri's healthcare needs, such as physicians and psychiatrists.

"As the demand for mental health services continues to rise, the expertise and dedication of our team will play a critical role in ensuring that individuals receive the care and support they need when they need it," said Dr. Deepika Vuppalanchi, CEO, Syra Health. "We are committed to providing affordable services that improve access to mental health resources and foster healthier communities."

ABOUT SYRA HEALTH

Syra Health is a healthcare technology company that is powering better health in challenging areas such as behavioral and mental health, digital health, and population health, by providing innovative and meaningful solutions. Syra Health's offerings are centered on prevention, improved access, and affordable care. Syra Health serves everyone working in healthcare. For more information, visit www.syrahealth.com.

 FORWARD-LOOKING STATEMENTS

Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy, and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Investors should read the risk factors set forth in our Form 10-K for the year ended December 31, 2023, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.

Contacts

For Media Inquiries:
Christine Drury
Communications and Marketing Director
Syra Health
463-345-5180
[email protected]

For Investor Inquiries:
Ben Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
[email protected]

SOURCE Syra Health